HIV fusion inhibitor peptides with improved biological properties
US7456251B2 · kind B2 · utility
5Cited by
42References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2007 |
| Grant date | Nov 25, 2008 |
| Priority date | — |
| Expiry date | Feb 2, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is an HIV fusion inhibitor peptide having an amino acid sequence of any one of SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, or SEQ ID NO:15; and provided is a pharmaceutical composition comprising a HIV fusion inhibitor peptide and one or more of a pharmaceutically acceptable carrier and macromolecular carrier, and uses and methods of treatment provided by these compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.